Nuclear Medicine and Molecular Imaging Essentials 2019

Kau 1: ʻO ke Kiʻi Oncologic

ʻO nā Metastases maʻi maʻi prostate: Nā mea hana hou a me ka lapaʻau ʻana	Olga Mochanova-Cook, MD, PhD
Nā palapala noi PET/MRI i ka Nucear Oncology	Ali Civelek, MD
Ke Kiʻi Molecular o ka ʻAha ʻAʻole Paʻa ʻole	Steven Rowe, MD
ʻO CAR T-Cell Therapy a me ke kuleana o ke kiʻi Molecular i ka nānā ʻana i ke ʻano o ka mālama ʻana.	Reza Sirous, MD

Kau 2: Neuro

Ka Evolving Role o PET/CT no ka Neuroendocrine Tumor Imaging	Daniel Pryma, MD
Ka mālama ʻana i nā maʻi me nā maʻi maʻi neuroendocrine i ka wā o Ga68 a me Lu177	Petr Hausner, MD
Nā Manaʻo ʻenehana a me nā Logistics o ka Lu-177 Therapy i ka Functional Neuro Endocrine Tumors	Ali Civelek, MD
ʻO ke kiʻi a me ka Therapy o Pheochromocytoma/Paraganglioma	Daniel Pryma, MD
Hoʻohālikelike o 18F-FDG PET / CT a me MRI i ka loiloi o nā maʻi me ka Antibody Positive Autoimmune Encephalitis	Krystyna Jones, MD

Kau 3: Ke Kiʻi Puʻuwai

Cardiac Sarcoidosis a me Amyloidosis Kiʻi	Panithaya Chareonthaitawee, MD
Ka Hoʻololi ʻana o ka PET i ka loiloi ʻana i ka Atherosclerosis a me nā maʻi Vascular ʻē aʻe	Abass Alavi, MD
Kiʻi maʻi maʻi naʻau	Wengen Chen, MD, PhD, FACNM

Kau 4: Nā noi i hala, i kēia manawa a me ka wā e hiki mai ana

Nā hopena o ke komo ʻana ma PET/CT	James Crowley, MHA, CNMT
Gastroesophageal Scintigraphy: Milk Scan a me Salivagram	Hongming Zhuang, MD
USP 727 a me 825	Richard Green, BSPharm, RPh, BCNP, FAPhA
18F-FDG-PET ʻO nā haʻawina o ka lāʻau lapaʻau	Abass Alavi, MD
Nā Pūnaehana PET ma muli o SiPM hou	Mark F. Smith, PhD, DABSNM
hihia Haʻawina	Mark Crosthwaite, M.Ed, CNMT, PET, FSMMMI-TS

Release Lā: 8/20/19
CME Pau: 8 / 19 / 22

Welina mai Kākoʻo